TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
NUVL

Nuvalent Inc

Healthcare · Biotechnology

124.00$ +0.0% vs. previous close Closing price · As of: Jul 21, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NUVL
Line item 2019 2020 2021 2022 2023 2024 2025
– +221.0% +2,659.9% +64.2% +51.8% +55.9% +23.7%
– +221.0% +2,629.9% +64.5% +52.0% +55.9% +23.0%
– +242.6% +563.2% +252.9% +38.7% -56.6% +79.7%
– +242.6% +2,688.5% +63.9% +52.5% +55.3% +22.7%
– – – +39.8% – – –
– +104.0% -79.1% +121.7% +63.4% +126.1% +128.4%
– +0.7% +100.6% +121.7% +63.4% +69.8% +68.8%
– -37.8% – – – – –
– +73.2% +131.1% +148.7% +28.9% -43.7% +477.2%
– +2.9% – – – – –
– – – +62.4% +51.3% +52.7% +16.7%
– – – – – – –
– -52.6% -4.7% +128.0% +17.2% +14.1% +9.5%

Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?